MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 31.2549

Change

+0.03 (+0.10)%

Market Cap

N/A

Volume

41.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-0.87 (-0.45%)

USD 30.45B
ACWI iShares MSCI ACWI ETF

-0.33 (-0.28%)

USD 18.45B
IBIT iShares Bitcoin Trust

+0.05 (+0.15%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.02 (-0.10%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.11 (-0.20%)

USD 15.58B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.56B
IBTF iShares iBonds Dec 2025 Term T..

-0.01 (-0.04%)

USD 2.34B
NVDL GraniteShares 1.5x Long NVDA D..

-2.07 (-3.89%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

-0.23 (-0.35%)

USD 2.01B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.90% 76% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.90% 74% C 70% C-
Trailing 12 Months  
Capital Gain 4.10% 43% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.10% 35% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.28% 51% F 44% F
Dividend Return 0.28% 45% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.09% 98% N/A 100% F
Risk Adjusted Return 25.40% 53% F 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector